Introduction {#sec1_1}
============

Five randomized trials have demonstrated the benefit of thrombectomy with a stent retriever or flexible aspiration catheter over medical therapy alone in patients with emergency large vessel occlusion \[[@B1], [@B2], [@B3], [@B4], [@B5], [@B6]\]. Mechanical thrombectomy is increasingly being used for treating acute large vessel occlusion as the first line of endovascular therapy. The use of mechanical thrombectomy devices allows for the retrieval of cerebral thrombi from intracranial vessels and subsequent histopathological analysis. Several studies have suggested that histopathological analysis of a retrieved clot is beneficial in predicting the stroke mechanism in acute large vessel occlusion \[[@B7], [@B8], [@B9], [@B10], [@B11]\]. However, very few studies have investigated the relationship between the histopathology of retrieved thrombi and the clinical outcomes \[[@B7], [@B8], [@B10], [@B12]\]. A recent study showed that patients with erythrocyte-rich thrombi had higher successful recanalization rates using a MERCI retriever and aspiration catheter \[[@B12]\]. At the present time, thrombectomy with a stent retriever is performed as first-line treatment for patients with acute large vessel occlusion, and has a significantly high rate of successful recanalization. Therefore, clarifying the association between the histopathology of retrieved thrombi and the procedure time is important.

The aim of this study was to evaluate thrombus composition and its association with clinical, laboratory, and neurointerventional findings in patients treated by mechanical thrombectomy due to acute large vessel occlusion.

Subjects and Methods {#sec1_2}
====================

Patients {#sec2_1}
--------

Patients with acute large vessel occlusion treated in our hospital by mechanical thrombectomy using a stent retriever and/or aspiration catheter due to internal carotid artery, middle cerebral artery, or basilar artery occlusion from August 2015 to August 2016 were included in this study. The patients underwent a nonenhanced computed tomography (CT) scan and a perfusion CT scan before endovascular therapy.

Subtypes of ischemic stroke were determined according to the international Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification. Large artery atherosclerosis was defined as angiographic findings of either significant (\>50%) stenosis or occlusion of a major cervical artery or intracranial artery ipsilateral to the symptomatic hemisphere without evidence of potential sources of cardioembolism in other diagnostic studies. Cardioembolism was defined as at least one cardiac source for an embolus identified in the absence of significant ipsilateral stenosis.

The institutional ethics committee approved this study. If a patient had the capacity to consent, written informed consent was obtained from the patient. If this was not the case, written informed consent was obtained from their nearest relatives.

CT Imaging Analysis {#sec2_2}
-------------------

CT imaging examinations were performed using a 64-slice multidetector CT device (GE Healthcare, Little Chalfont, UK). The CT parameters of the noncontrast CT were 120 kVp, 300 mAs, and a 5-mm reconstructed slice thickness. For the perfusion CT, 40 mL of contrast agent (iohexol) was injected into the antecubital vein (20-G needle) at a rate of 4 mL/s followed by a 20-mL saline flush at the same rate.

Thrombus attenuation was measured on 3-mm noncontrast CT images in Hounsfield units (HU) by two investigators blinded to any data except the localization of the thrombus. Within the thrombus, a standardized small, round region of interest was drawn, and the mean HU values were used for analysis.

Procedure of Mechanical Thrombectomy {#sec2_3}
------------------------------------

On admission, a stroke neurologist performed an assessment based on the NIHSS. The inclusion criteria for endovascular thrombectomy were as follows: (1) an NIHSS score \>4, with no intracranial hemorrhage detected on cranial CT imaging; (2) a small infarct core, defined as an ASPECTS (Alberta Stroke Programme Early CT Score) of 6--10; and (3) a target mismatch pattern on perfusion CT imaging. The occluded vessel was detected on four-dimensional CT angiography.

Cerebral angiography and mechanical recanalization were performed under local anesthesia. In case of agitation, intravenous infusion of propofol was conducted. Stent-based thrombectomy with a Solitaire stent (Covidien, Irvine, CA, USA), a Trevo retriever (Stryker, Kalamazoo, MI, USA), or Revive (Codman Neuro, Raynham, MA, USA) was performed as the first-line endovascular treatment. When the location of a thrombus was M1 distal or M2, a Penumbra 5MAX ACE (Penumbra, Alameda, CA, USA) was used as an intermediate catheter. When the stent-based thrombectomy was unsuccessful, additional approaches were performed, including using a Penumbra reperfusion catheter and intra-arterial injection of urokinase. The recanalization status was assessed on the final angiogram and was classified according to the modified TICI (Thrombolysis in Cerebral Infarction) scale, with successful recanalization defined as a modified TICI grade of 2b or 3. Clinical outcome was assessed by a stroke neurologist using the modified Rankin Scale (mRS) at 90 days after treatment. A good outcome was defined as an mRS score of 0--2 or no change. A patient was excluded due to death from lung cancer 2 months after thrombectomy.

Histopathological Analysis {#sec2_4}
--------------------------

The retrieved thrombus material was fixed in 10% neutralized buffered formalin immediately after retrieval. The formalin-fixed, paraffin-embedded thrombus was cut at 2-μm thickness. All thrombi were stained with hematoxylin-eosin. The slides with the stained specimens were scanned at ×200 with a DP 72 device (Olympus, Tokyo, Japan) and digitally stored. The ImageJ software (National Institutes of Health, Bethesda, MD, USA) and Photoshop Elements 14 (Adobe Systems Inc., San Jose, CA, USA) were used for the relative quantitative analysis of erythrocytes, fibrin, and leukocytes using color-based segmentation (Fig. [1](#F1){ref-type="fig"}). Thrombi were classified as erythrocyte rich or fibrin rich according to their predominant composition (Fig. [2](#F2){ref-type="fig"}). The histopathological analysis was performed by an experienced pathologist and an investigator blinded to the clinical and interventional data. The histopathological assessment included organization, degree of the main composition, presence of calcifications, cholesterol crystals, and endothelial cells.

Statistical Analysis {#sec2_5}
--------------------

The baseline characteristics are summarized as means (with standard deviation \[SD\]), medians (with range), or frequency counts and proportions. For comparisons between categorical variables, the χ^2^ test was used. The Student *t* test was used in case of variables with a normal distribution. The Mann-Whitney U test was used in case of variables with a nonnormal distribution. The two-sided Spearman coefficient was used to express correlations between specific thrombus parameters and clinical and interventional parameters. The statistical analysis was performed using EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan) and SPSS (version 24.0; SPSS, Inc., Chicago, IL, USA). *p* values \<0.05 were considered significant. All analyses were retrospective and performed in an explorative manner.

Results {#sec1_3}
=======

During the study period, 79 consecutive patients were treated in our hospital by mechanical thrombectomy using a stent retriever and/or aspiration catheter due to internal carotid artery, middle cerebral artery, or basilar artery occlusion. In 6 patients, no recanalization could be achieved (TICI score 0), whereas 2 patients reached a TICI score of 2a, and 71 patients reached a TICI score of 2b or 3. In 36 patients, no evaluable thrombus material could be retrieved. Thrombi were available for analysis in 43 cases (22 female, aged 43--95 years, median 76), with erythrocyte-rich thrombi present in 42% (18/43) of the cases and fibrin-rich thrombi present in 58% (25/43) of the cases.

Preprocedural and Procedural Parameters {#sec2_6}
---------------------------------------

The clinical characteristics were generally similar (Table [1](#T1){ref-type="table"}), but the patients with fibrin-rich thrombi had a significantly higher percentage of cardioembolism and lower thrombus density in HU when compared with the patients with erythrocyte-rich thrombi (Table [1](#T1){ref-type="table"}). There was a weak positive correlation between erythrocyte and thrombus attenuation (*R* = 0.30, *p* = 0.06). There was no significant difference in the percentage of recombinant tissue plasminogen activator infusion (Table [1](#T1){ref-type="table"}).

The patients with erythrocyte-rich thrombi required a smaller number of recanalization maneuvers (1.8 ± 1.1 vs. 2.9 ± 1.5; *p* = 0.02), had a shorter procedure time (median 24.5 min \[8--85\] vs. 44 min \[13--129\]; *p* \< 0.01), and had a shorter arrival-to-recanalization time interval (median 86.5 min \[32--146\] vs. 110 min \[58--222\]; *p* = 0.04). The patients with erythrocyte-rich thrombi had a higher percentage of stent retrievers in the final recanalization procedure (72 vs. 36%; *p* = 0.04) (Table [2](#T2){ref-type="table"}).

Procedure time was correlated with erythrocyte infiltration (*R* = −0.34; *p* = 0.02) and fibrin infiltration (*R* = 0.35; *p* = 0.02) (Fig. [3](#F3){ref-type="fig"}). There was no significant correlation between procedure time and leukocyte infiltration (*R* = 0.25; *p* = 0.11) (Fig. [3](#F3){ref-type="fig"}).

Outcome Measures {#sec2_7}
----------------

A patient with a fibrin-rich thrombus had a TICI score of 2a, the other patients had TICI scores of 2b or 3. The patients with erythrocyte-rich thrombi had a tendency for a more favorable clinical outcome (mRS score 0--2 or no change at 90 days; 71 vs. 36%; *p* = 0.06) (Table [3](#T3){ref-type="table"}).

Histopathological Findings {#sec2_8}
--------------------------

All clots displayed a heterogeneous pattern of three different components: fibrin, erythrocytes, and leukocytes. There were no cholesterol crystals, calcified materials, smooth-muscle cells, or other components of the intima or vessel wall structures.

The subtypes of stroke were classified as large artery atherosclerosis (TOAST 1) in 5 cases (12%), cardioembolism (TOAST 2) in 30 cases (70%), another determined etiology (TOAST 4) in 1 case (2%), and an undetermined etiology (TOAST 5) in 7 cases (16%). A single patient in TOAST class 4 had a vertebral artery dissection. Of the 7 patients classified in TOAST class 5, 1 patient had atrial fibrillation and lung cancer, and 6 patients were diagnosed with cryptogenic stroke. Transesophageal echocardiography was performed in all of the cases classified as cryptogenic.

Stroke Etiology {#sec2_9}
---------------

The clots in the patients with a cardioembolism contained a higher proportion of fibrin (66.2 ± 25.8 vs. 46.4 ± 25.5%; *p* = 0.03) and a lower proportion of erythrocytes (29.5 ± 26.2 vs. 49.6 ± 26.1%; *p* = 0.03) than those in the patients with no cardioembolism (Fig. [4](#F4){ref-type="fig"}). The large artery atherosclerotic and cryptogenic thrombi had a higher percentage of erythrocytes. There was no significant difference in the percentage of leukocytes between the patients with cardioembolism and those with no cardioembolism.

Discussion {#sec1_4}
==========

This study shows that (1) erythrocyte-rich thrombi were associated with a smaller number of recanalization maneuvers, shorter procedure time, and shorter arrival-to-recanalization time interval, (2) erythrocyte-rich thrombi have a higher thrombus density in HU, and (3) cardioembolic thrombi have a higher percentage of fibrin and fewer erythrocytes than noncardioembolic thrombi.

Interestingly, a significant relationship between thrombus composition and clinical outcome was observed. Erythrocyte-rich thrombi were associated with a smaller number of recanalization maneuvers, shorter procedure time, and shorter arrival-to-recanalization time interval. At our institution, we perform mechanical thrombectomy with a stent retriever as the first-line therapy. Patients with erythrocyte-rich thrombi had successful recanalization using the stent retriever, whereas those with fibrin-rich thrombi had failed recanalization using a stent retriever and underwent successful recanalization using an aspiration catheter. To date, very few studies have investigated the relationship between the histopathology of retrieved thrombi and clinical outcomes. One recent study described that patients with erythrocyte-rich thrombi had a higher successful recanalization rate with a MERCI retriever and an aspiration catheter \[[@B12]\]. Moreover, in a stent retriever-based study, thrombus density measured in HU (undoubtedly reflecting higher erythrocyte infiltration) was strongly predictive of successful recanalization \[[@B13]\]. Recently, thrombectomy with a stent retriever has been performed as first-line therapy for patients with acute large vessel occlusion, and it had a significantly higher rate of successful recanalization.

Patients with erythrocyte-rich thrombi had a shorter arrival-to-recanalization time interval and had more favorable clinical outcomes, whereas there was no significant difference in symptom onset-to-recanalization time interval. Recent publications have described a stronger association of good outcome with the time interval from arrival at the emergency department to recanalization, but not with the time interval from symptom onset to arrival at the emergency department \[[@B14]\]. This may be because the inclusion criteria eliminated patients with clinical features of a very mild ischemic injury, clinical and brain imaging features that indicated an advanced and extensive injury, or an unknown or undocumented time of stroke onset. In contrast, the time of arrival at the emergency department is generally accurately documented in patients' medical records \[[@B15]\]. In some patients, symptom onset occurs during sleep and the actual time of symptom onset is not known.

Several studies have investigated a possible relationship between the histology of retrieved thrombi and stroke etiology \[[@B7], [@B8], [@B9], [@B10], [@B11], [@B16], [@B17]\]. In our study, we found that the proportion of fibrin in retrieved thrombi was higher in patients with cardioembolism than in those with no cardioembolism. This is in line with the findings of Boeckh-Behrens et al. \[[@B7], [@B8]\] and Niesten et al. \[[@B10]\]. They reported that cardioembolic thrombi were more organized than noncardioembolic thrombi. Fresh erythrocyte-rich thrombi may occur around the local plaque rupture, or organized thrombi can embolize to the brain incompletely, which may ultimately lead to complete thrombosis \[[@B7]\]. Our results seem to be in contrast to a published study by Ha et al. \[[@B9]\], questioning the traditional concept of cardioembolic thrombi being mostly erythrocyte-rich thrombi. A recent systematic review showed no association between thrombus composition and etiology \[[@B17]\]. All previous studies that reported a correlation between thrombus histology and stroke etiology used hematoxylin-eosin staining to evaluate thrombus composition. They reported that hematoxylin-eosin staining characteristics did not provide enough information to understand the association between thrombus composition and stroke etiology, and immunostaining was required to further understand it.

Our study shows that erythrocyte-rich thrombi have a higher density on CT than fibrin-rich thrombi. Pranevicius et al. \[[@B16]\] reported that the mean percentage of erythrocytes was greater in thrombi with hyperdense middle cerebral artery signs. Niesten et al. \[[@B18]\] showed a relationship between higher thrombus density and noncardioembolism. On the other hand, the susceptibility vessel sign on T2\*-weighted gradient echo imaging or susceptibility-weighted imaging, which reflects a high amount of erythrocytes, was related to cardioembolism \[[@B9], [@B16], [@B19]\]. This discrepancy may be due to a thrombus\'s age. These sequences detect the paramagnetic effects of deoxyhemoglobin and methemoglobin. Fresh erythrocyte-rich thrombi still contain significant amounts of diamagnetic oxyhemoglobin, while old cardio­embolic thrombi have time to become fully deoxygenated and paramagnetic \[[@B20], [@B21]\].

Our study has several limitations. Only a relatively small number of thrombi were investigated, making it difficult to draw any strong conclusions. There may be a selection bias toward more stable thrombi, as not all thrombi or thrombus fragments retrieved could be included in the final analysis due to disintegration during retrieval or histological processing. In addition, we investigated patients with acute large vessel occlusion in 54% of all cases treated in our hospital. Furthermore, patients with investigated thrombi had successful reperfusion (TICI 2b or 3) in 96% of the cases. Thus, we could not evaluate retrieved thrombi from patients with unsuccessful reperfusion.

Conclusion {#sec1_5}
==========

Erythrocyte-rich thrombi were associated with a reduced number of recanalization maneuvers, shorter arrival-to-recanalization time interval, and more favorable clinical outcomes. This study suggests that the histological composition of retrieved thrombi is significantly different between stroke subtypes. Cardioembolic thrombi have a higher percentage of fibrin and fewer erythrocytes than do noncardioembolic thrombi. In addition, a high thrombus density in HU is strongly associated with erythrocyte-rich thrombi. These findings will have to be validated in future studies.
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![Histopathological analysis of a retrieved thrombus using the ImageJ software. **a** Pathology image of a thrombus stained with hematoxylin-eosin. **b** Leukocytes are depicted in red. Leukocytes represent 3% of the total composition in this image. **c** Erythrocytes are depicted in red. Erythrocytes represent 29% of the total composition in this image. **d** Fibrin is depicted in red. Fibrin represents 68% of the total composition in this image. These procedures were performed on all parts of the thrombus. This thrombus was finally categorized as fibrin rich.](cee-0008-0039-g01){#F1}

![Histopathology of erythrocyte-rich and fibrin-rich thrombi. ×200. **a** Erythrocyte-rich thrombus displaying a predominance of erythrocyte infiltration and lower fibrin infiltration. **b** Fibrin-rich thrombus displaying a predominance of organized fibrin infiltration with few cellular elements.](cee-0008-0039-g02){#F2}

![Procedure time was correlated with erythrocyte infiltration (**a**), fibrin infiltration (**b**), and leukocyte infiltration (**c**).](cee-0008-0039-g03){#F3}

![Differences in mean percentages of thrombus composition by Trial of Org 10172 in Acute Stroke Treatment (TOAST) class. Leukocyte (**a**), erythrocyte (**b**), and fibrin infiltration (**c**).](cee-0008-0039-g04){#F4}

###### 

Differences in preprocedural and procedural parameters between the two groups

                                                         Erythrocyte rich (*n* = 18)   Fibrin rich (*n* = 25)   *p* value
  ------------------------------------------------------ ----------------------------- ------------------------ -----------
  Age, years                                             75.2±14                       77.6±13.9                0.58
  Female, *n* (%)                                        9 (50)                        13 (52)                  1
  Baseline NIHSS score                                   20.3±9.2                      20.2±6.3                 0.97
  Diabetes mellitus, *n* (%)                             2 (11)                        2 (8)                    1
  Hypertension, *n* (%)                                  6 (33)                        15 (60)                  0.16
  Anticoagulation agent, *n* (%)                         5 (28)                        6 (24)                   0.77
  Antiplatelet agent, *n* (%)                            4 (22)                        2 (8)                    0.18
  Stroke etiology according to TOAST criteria, *n* (%)                                                          
   Large artery atherosclerosis (TOAST 1)                3 (17)                        2 (8)                    0.63
   Cardioembolism (TOAST 2)                              9 (50)                        21 (84)                  0.01
   Other determined cause (TOAST 4)                      1 (6)                         0 (0)                    0.42
   Other undetermined cause (TOAST 5)                    5 (29)                        2 (7)                    0.07
  Occlusion site, *n* (%)                                                                                       
   ICA                                                   8 (44)                        10 (40)                  1
   M1 proximal                                           3 (17)                        5 (20)                   1
   M1 distal                                             2 (11)                        5 (19)                   0.68
   M2                                                    2 (11)                        4 (15)                   1
   Basilar artery                                        3 (17)                        1 (4)                    0.29
  ASPECTS                                                9.1±2.5                       8.9±2.1                  0.6
  Thrombus density, HU                                   48.1 (24.7--55.1)             32.1 (27--41.8)          0.04
  Infusion of tissue plasminogen activator, *n* (%)      10 (56)                       10 (40)                  0.49
  Symptom onset to puncture time interval, min           225 (85--2,064)               191 (60--1,324)          0.65
  Mechanical thrombectomy device, *n* (%)                                                                       
   Stent retriever                                       15 (83)                       23 (92)                  0.81
   Aspiration catheter                                   13 (72)                       21 (84)                  0.77
  Procedure time, min                                    24.5 (8--85)                  44 (13--129)             \<0.01
  Arrival-to-recanalization time interval, min           86.5 (32--146)                110 (58--222)            0.04
  Symptom onset-to-recanalization time interval, min     256 (128--2,100)              268 (100--1,367)         0.4
  Number of recanalization maneuvers                     1.8±1.1                       2.9±1.5                  0.02

Values are presented as means ± SD or medians (range) unless specified otherwise. Procedure time is the time interval between catheterization of the balloon guiding catheter and recanalization. NIHSS, National Institutes of Health Stroke Scale; TOAST, Trial of Org 10172 in Acute Stroke Treatment; ICA, internal carotid artery; ASPECTS, Alberta Stroke Programme Early CT Score; HU, Hounsfield units.

###### 

Differences in final recanalization procedures between the study groups

                                          Erythrocyte rich (*n* = 18)   Fibrin rich (*n* = 25)   *p* value
  --------------------------------------- ----------------------------- ------------------------ -----------
  Stent retriever                         13 (72%)                      9 (36%)                  0.04
  Aspiration catheter                     4 (22%)                       14 (56%)                 0.06
   Adapt first                            1 (6%)                        2 (8%)                   1
   Stent first, adapt second              1 (6%)                        8 (32%)                  0.08
   For distal migration                   2 (11%)                       4 (16%)                  1
  Intra-arterial injection of urokinase   1 (6%)                        2 (8%)                   1

###### 

Differences in outcome measures between the two groups

                                           Erythrocyte rich (*n* = 18)                 Fibrin rich (*n* = 25)   *p* value
  ---------------------------------------- ------------------------------------------- ------------------------ -----------
  TICI class 2b or 3                       18 (100%)                                   24 (96%)                 1
  mRS score 0--2 or no change at 90 days   11 (71%)[^1^](#T3F1){ref-type="table-fn"}   9 (36%)                  0.06

TICI, Thrombolysis in Cerebral Infarction; mRS, modified Rankin Scale.

*n* = 17.
